EU Commission wants to exclude devices from SRM (specified risk material) ban
This article was originally published in Clinica
The European Commission is proposing that medical devices remain excluded from the forthcoming Commission Decision that will ban the use of specified risk materials (SRMs) from animals. It is arguing that devices should not be included on the grounds that risk is already minimised by sector-specific requirements. The Commission also wishes to ensure that they are excluded from coverage under the European Regulation on transmissible spongiform encephalopathies (TSEs), currently being developed.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.